1. Home
  2. MYGN vs WLKP Comparison

MYGN vs WLKP Comparison

Compare MYGN & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYGN
  • WLKP
  • Stock Information
  • Founded
  • MYGN 1991
  • WLKP 2014
  • Country
  • MYGN United States
  • WLKP United States
  • Employees
  • MYGN N/A
  • WLKP N/A
  • Industry
  • MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • WLKP Major Chemicals
  • Sector
  • MYGN Health Care
  • WLKP Industrials
  • Exchange
  • MYGN Nasdaq
  • WLKP Nasdaq
  • Market Cap
  • MYGN 642.0M
  • WLKP 741.1M
  • IPO Year
  • MYGN 1995
  • WLKP 2014
  • Fundamental
  • Price
  • MYGN $7.88
  • WLKP $21.04
  • Analyst Decision
  • MYGN Hold
  • WLKP
  • Analyst Count
  • MYGN 13
  • WLKP 0
  • Target Price
  • MYGN $13.50
  • WLKP N/A
  • AVG Volume (30 Days)
  • MYGN 1.5M
  • WLKP 50.5K
  • Earning Date
  • MYGN 11-06-2025
  • WLKP 11-04-2025
  • Dividend Yield
  • MYGN N/A
  • WLKP 8.99%
  • EPS Growth
  • MYGN N/A
  • WLKP N/A
  • EPS
  • MYGN N/A
  • WLKP 1.49
  • Revenue
  • MYGN $832,900,000.00
  • WLKP $1,101,803,000.00
  • Revenue This Year
  • MYGN $0.17
  • WLKP $3.27
  • Revenue Next Year
  • MYGN $6.19
  • WLKP $13.98
  • P/E Ratio
  • MYGN N/A
  • WLKP $14.04
  • Revenue Growth
  • MYGN 3.83
  • WLKP N/A
  • 52 Week Low
  • MYGN $3.76
  • WLKP $20.63
  • 52 Week High
  • MYGN $26.60
  • WLKP $25.04
  • Technical
  • Relative Strength Index (RSI)
  • MYGN 57.10
  • WLKP 41.69
  • Support Level
  • MYGN $7.04
  • WLKP $20.80
  • Resistance Level
  • MYGN $8.25
  • WLKP $21.45
  • Average True Range (ATR)
  • MYGN 0.38
  • WLKP 0.37
  • MACD
  • MYGN -0.06
  • WLKP 0.02
  • Stochastic Oscillator
  • MYGN 54.77
  • WLKP 35.92

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests

Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.

Share on Social Networks: